StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)

Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –

InfuSystem Holdings, Inc grew revenue 2.4% to $144.44M over the twelve months to Sep 30, 2026. Operating income rose 31.2% to $14.20M, moving the operating margin from 7.7% to 9.8%. Free cash flow was $24.76M, up 2.1% from a year earlier. At the latest close the market valued the company at $293.18M, 32.7 times its earnings.

Revenue
$144.44M
+2.4% vs. a year earlier
Operating income
$14.20M
+31.2% vs. a year earlier
Free cash flow
$24.76M
+2.1% vs. a year earlier
EPS, diluted
$0.45
+73.1% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$293.18M
P/E ratio
32.7
Price to sales
2.03
Price to book
4.57
Dividend yield
–
Free cash flow yield
8.45%

Fundamentals

Revenue
$144.44M
Net income
$9.44M
EPS, diluted
$0.45
Free cash flow
$24.76M
Book value per share
$3.04
Diluted shares
21M

Trading

Next earnings
Feb 23, 2027 (estimated, before the open)
Previous close
$14.79
Open
$14.77
Day's range
$14.67 – $15.06
Volume
144,991
Average volume (20 days)
155,532
Index membership
Russell 2000 (since Jun 2026)
Beta (5 years)
1.18
52-week range
$7.29 – $15.47
RSI (14 days)
59.3
Volatility (1 year)
57.0%
Relative volume
1.03×
WACC
10.6%

Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2010, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodINFUS&P 500DifferenceINFU per yearS&P 500 per year
1 month+9.1%-3.0%+12.2 pts
3 months+17.9%-2.8%+20.7 pts
Year to date+64.1%+11.5%+52.6 pts
1 year+44.9%+13.5%+31.4 pts
3 years+67.3%+77.7%−10.4 pts+18.7%+21.1%
5 years-7.7%+72.6%−80.3 pts-1.6%+11.5%
10 years+674.7%+308.2%+366.6 pts+22.7%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$144.44M+2.4% YoY

Gross profit

$83.26M+6.6% YoY

Operating income

$14.20M+31.2% YoY

Net income

$9.44M+70.9% YoY

EPS, diluted

$0.45+73.1% YoY

Free cash flow

$24.76M+2.1% YoY
Reported periodTrailing twelve months

Press releases

Releases InfuSystem filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About InfuSystem

Surgical & Medical Instruments & Apparatus

InfuSystem Holdings, Inc. operates as a healthcare service provider facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. The company provides ambulatory infusion pumps, negative pressure wound therapy devices, related disposable supplies, and biomedical services, including inspection, repair, and certification. Business activities are organized into two operational segments: Patient Services and Device Solutions. Patient Services focuses on clinic-to-home healthcare delivery, continuous chemotherapy infusion, pain management, and wound care, accompanied by third-party billing and clinical support. Device Solutions provides equipment sales, rentals, consumable distribution, and direct biomedical maintenance services to clinical practices. InfuSystem serves hospitals, oncology practices, ambulatory surgery centers, infusion clinics, home care providers, skilled nursing facilities, and acute care facilities.

Company profile, executives and history

InfuSystem stock: common questions

What is InfuSystem's stock price?

INFU closed at $14.72 on Nov 13, 2026, down 0.47% on the day. Over the past 52 weeks it traded between $7.29 and $15.47.

What is InfuSystem's market cap?

InfuSystem was worth $293.18M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is INFU's P/E ratio?

INFU trades at 32.7 times earnings, based on diluted earnings per share of $0.45 over the twelve months to Sep 30, 2026.

How much revenue does InfuSystem make?

InfuSystem reported revenue of $144.44M for the twelve months to Sep 30, 2026, up 2.4% from a year earlier.

Does InfuSystem pay a dividend?

No. InfuSystem has not paid a cash dividend over the last twelve months.

When does InfuSystem report earnings next?

InfuSystem is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has INFU stock performed over the past year?

Including dividends, INFU returned +44.9% over the past year, against +13.5% for the S&P 500.

How many INFU shares are sold short?

1M shares were sold short at the latest FINRA report, 3.91% of the float, or 5.7 days of average trading volume.

Who are InfuSystem's competitors?

Companies most similar to InfuSystem by business, industry and size include DCTH, IRMD, ANGO, KRMD, STIM.

See a number that looks wrong?